Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Ingrid Sjögren"'
Autor:
Vivi F. H. Jensen, Line H. Schefe, Helene Jacobsen, Anne-Marie Mølck, Kasper Almholt, Ingrid Sjögren, Charlotte M. Dalsgaard, Rikke K Kirk, Andrew J. Benie, Bent O. Petersen, Mette S. Kyhn, Anne J. Overgaard, Inga Bjørnsdottir, Diane R. Stannard, Hanne K. Offenberg, Emil Egecioglu
Publikováno v:
International journal of toxicology. 41(6)
N9-GP/Rebinyn®/Refixia® is an approved PEGylated (polyethylene glycol-conjugated) recombinant human factor IX intended for prophylactic and/or on-demand treatment in adults and children with haemophilia B. A juvenile neurotoxicity study was conduct
Autor:
Anne-Marie Mølck, Ingrid Sjögren, Jette Nowak, Vivi F. H. Jensen, Inger Thorup, Peter R. Brinck
Publikováno v:
International Journal of Toxicology. 39:560-576
For nonclinical safety-assessment of insulin analogues in vivo, mitogenic effects are compared to that of human insulin. Besides histopathologic evaluation, this usually includes assessment of cell proliferation (CP) in mammary glands. Insulin analog
Autor:
Johannes Josef Fels, Henrik Søeborg, Inger Thorup, Mikala Skydsgaard, Lærke W. Andersen, Hanne Offenberg, Kevin A. Keane, Charlotte M. Dalsgaard, Ingrid Sjögren, Jennifer M. Rojas, Line Olrik Berthelsen, Jette Nowak, Florian Bolze, Jes Tovborg Jensen, Majken Dalgaard
Publikováno v:
Toxicologic Pathology. 46:777-798
The obese rodent serves as an indispensable tool for proof-of-concept efficacy and mode-of-action pharmacology studies. Yet the utility of this disease model as an adjunct to the conventional healthy animal in the nonclinical safety evaluation of ant
Autor:
Olivier Meyer, Ingrid Sjögren, Aileen Milne, Anders B. Lassen, Warren Harvey, Nils Dragsted, Rastislav Bator, Julie M. Larsen, Alys Bradley, Ninette K. Andersen
Publikováno v:
Journal of pharmacological and toxicological methods. 87
Introduction The novel PhysioTel™ Digital M11 telemetry implant was evaluated in socially housed monkeys with respect to both safety pharmacological cardiovascular (arterial blood pressure (BP), heart rate (HR) and electrocardiogram (ECG)) and toxi
Autor:
Torben S. Guldberg, Peter R. Brinck, Inger Thorup, Anne Charlotte Hegelund, Marianne B. Jensen, Ulla K. Thinggaard, Ingrid Sjögren, Henriette S. Nielsen, Lars Fogh Iversen, Martin B. Oleksiewicz, Hanne V. Andersen, Lis Jørgensen
Publikováno v:
Toxicologic Pathology. 33:552-560
Some developmental dual-acting PPARα/γ agonists, such as ragaglitazar, have shown carcinogenic effects in the rodent urinary bladder urothelium after months-years of dosing. We examined early (precancerous) changes in the bladder urothelium of rats
Autor:
Sushil K. Vundavalli, Ingrid Sjögren, Carsten F. Gotfredsen, Lotte Bjerre Knudsen, Anne Sietske de Boer, Lene Nonboe Andersen, Lars Wichmann Madsen, Katia Manova, Anne Marie Moelck, Andrew M. Pilling, Jeffrey A. Knauf, Søren Andersen, Niels C. Berg Nyborg, James A. Fagin, Afsar Barlas
Liraglutide and exenatide are glucagon-like peptide receptor (GLP-1R) agonists used in the treatment of type 2 diabetes. Both molecules have been associated with the development of thyroid C-cell tumors after lifetime exposure in rodents. Previously,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7f6a59e55953f28e3d3158813ed885e
https://europepmc.org/articles/PMC3281535/
https://europepmc.org/articles/PMC3281535/
Publikováno v:
Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie. 63(4)
In toxicopathological studies of the rat mammary glands, the guidelines of the Registry of Industrial Toxicology and Animal Data (RITA) recommend transverse sections of the inguinal mammary gland. However, occasionally limited amounts of mammary glan
Publikováno v:
Kappelgaard, A A, Bojesen, A, Skydsgaard, K, Sjögren, I & Laursen, T 2004, ' Liquid Growth Hormone: Preservatives and Buffers ', Hormone Research, vol. 62, no. Suppl.3, pp. 1197-16 .
Kappelgaard, A-M, Anders, B, Skydsgaard, K, Sjögren, I & Laursen, T 2004, ' Liquid growth hormone: preservatives and buffers ', Hormone Research, vol. 62, no. Suppl.3, pp. 98-103 . < http://www.ncbi.nlm.nih.gov/pubmed/15539807 >
Scopus-Elsevier
Kappelgaard, A-M, Anders, B, Skydsgaard, K, Sjögren, I & Laursen, T 2004, ' Liquid growth hormone: preservatives and buffers ', Hormone Research, vol. 62, no. Suppl.3, pp. 98-103 . < http://www.ncbi.nlm.nih.gov/pubmed/15539807 >
Scopus-Elsevier
Growth hormone (GH) treatment is a successful medical therapy for children and adults with GH deficiency as well as for growth retardation due to chronic renal disease, Turner syndrome and in children born small for gestational age. For all of these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::886909121b15ff2804ffa661d747623e
https://pure.au.dk/portal/da/publications/liquid-growth-hormone-preservatives-and-buffers(1f93bef0-fd23-11da-bee9-02004c4f4f50).html
https://pure.au.dk/portal/da/publications/liquid-growth-hormone-preservatives-and-buffers(1f93bef0-fd23-11da-bee9-02004c4f4f50).html
Publikováno v:
Growth factors (Chur, Switzerland). 14(1)
Several studies have suggested that growth factors play an important role in the development and the maintenance of the gastrointestinal tract. Colostrum and normal breast milk as well as intestinal secretion are reported to contain IGF-I. Thus, the
Autor:
Ingrid Sjögren, Sivert Bjurström
Publikováno v:
Experimental and Toxicologic Pathology. 57:333